http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-120440-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
filingDate 2020-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef8bdd6151540ee662b44ae99cd363f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f58d9b2358d4f9b70266d63a047b099
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79de3ecd2d7c93b43e30bc68af2d6796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04eef471b2b7f7a240c6f3b9750f84b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5dcaf3cdb1a90b6295936b7ab5f6986
publicationDate 2022-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-120440-A1
titleOfInvention NPY2 RECEPTOR AGONISTS
abstract PYY analogs having alanine at position 4, lysine at position 7, QRY as the C-terminal end, and a half-life extension group. The analogs are soluble around pH 6 and 7. Also pharmaceutical compositions comprising such PYY analogs and the medical use of the analogs.
priorityDate 2019-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457585837

Total number of triples: 24.